Global Nuclear Medicine Market Growth Drivers Research 2023

The nuclear medicine market is projected to reach USD 5.26 billion by 2023 from USD 3.95 billion in 2018. Factors such as the growing incidence and prevalence of cancer and cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99, are driving market growth.

Click   Here   for  Sample   Report   on    Nuclear   Medicine   Market     spread   across    213  Pages, Profiling 9 Companies and Supported with 250 Tables and 34 Figures at http://www.rnrmarketresearch.com/contacts/request-sample?rname=88290 .

Nuclear medicine is a medical specialty that uses radioactive tracers (radiopharmaceuticals) to assess bodily functions and to diagnose and treat disease. Specially designed cameras allow doctors to track the path of these radioactive tracers.

Premium Insights

1 Nuclear Medicine: Market Overview

2 Geographic Analysis: Nuclear Medicine Market for Pet Applications, By Type (2017)

3 Nuclear Medicine Market Share, By Type, 2018 vs 2023

4 Geographical Snapshot of the Nuclear Medicine Market

The major application areas of SPECT nuclear medicine include cardiology, lymphoma, thyroid, neurology and others (prostate cancer diagnosis, bone scans, and white cell scans).The thyroid applications segment is expected to register the highest CAGR during the forecast period.

Click Now for More Details on “Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT (Technetium), PET (F-18)), Therapeutic (Beta Emitters (I-131), Alpha Emitters, Brachytherapy(Y-90))), Application (Oncology, Thyroid, Cardiology) – Global Forecasts to 2023”report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=88290 .

Asia Pacific is expected to register the highest CAGR during the forecast period. The major factors driving the growth of this regional segment include research initiatives in Japan and the rising installations of PET scanners in India and China.

Break of primary participants was as mentioned below:

By Company Type – Tier 1:54%, Tier 2:34%, and Tier 3:12%

By Designation – C-level:31%, Director Level:19%, Others:50%

By Region – North America:46%, Europe:25%, Asia Pacific:18%, RoW:11%

The report analyzes the market and aims at estimating the size and the future growth potential of this market based on various segments such as type, application, procedural volume, and region. The report also includes the competitive landscape of the key players along with their company profiles, product offerings, recent developments, and key market strategies.

Target Audience:

1 Diagnostic laboratories

2 Hospitals

3 Venture capitalists

Request for call back:

[email protected]  / Call +1 888 391 5441

For further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness.